BRCA1 and neoplasm: For example, deletions of BRCA1/2 leads to DNA damage repair deficiencies in certain tumours [155, 156], and tumours with a large fraction of complex SVs generate vast amounts of neoantigens that may confer susceptibility to immune therapies [157, 158].